Gladius Capital Management LP Nkarta, Inc. Transaction History

Gladius Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 18, 2023	BUY	$2.19 - $5.17 $10,104 - $23,854	4,614 New	4,614 $10,000
Q2 2023 Aug 08, 2023	SELL	$2.19 - $5.17 $4,498 - $10,619	-2,054 Reduced 30.8%	4,614 $11,000
Q1 2023 Dec 18, 2023	BUY	$3.37 - $6.3 $22,471 - $42,008	6,668 New	6,668 $23,000
Q1 2023 May 09, 2023	BUY	$3.37 - $6.3 $7,124 - $13,318	2,114 Added 46.42%	6,668 $24,000
Q4 2022 Dec 18, 2023	BUY	$5.14 - $14.35 $23,407 - $65,349	4,554 New	4,554 $27,000
Q4 2022 Feb 02, 2023	BUY	$5.14 - $14.35 $23,407 - $65,349	4,554 New	4,554 $28,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.